ATE414281T1 - Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k - Google Patents

Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k

Info

Publication number
ATE414281T1
ATE414281T1 AT06016205T AT06016205T ATE414281T1 AT E414281 T1 ATE414281 T1 AT E414281T1 AT 06016205 T AT06016205 T AT 06016205T AT 06016205 T AT06016205 T AT 06016205T AT E414281 T1 ATE414281 T1 AT E414281T1
Authority
AT
Austria
Prior art keywords
pi3k
phenylthiazole ligand
immobilized
phenylthiazole
ligand
Prior art date
Application number
AT06016205T
Other languages
English (en)
Inventor
Moore Giovanna Bergamini
Andrew Cansfield
Nigel Ramsden
Gitte Neubauer
Original Assignee
Cellzome Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ag filed Critical Cellzome Ag
Application granted granted Critical
Publication of ATE414281T1 publication Critical patent/ATE414281T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
AT06016205T 2006-08-03 2006-08-03 Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k ATE414281T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06016205A EP1887359B1 (de) 2006-08-03 2006-08-03 Verfahren zur Identifizierung von Molekülen die mit PI3K interagieren und Verfahren zur Reinigung von PI3K

Publications (1)

Publication Number Publication Date
ATE414281T1 true ATE414281T1 (de) 2008-11-15

Family

ID=37635850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06016205T ATE414281T1 (de) 2006-08-03 2006-08-03 Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k

Country Status (12)

Country Link
US (1) US8153389B2 (de)
EP (1) EP1887359B1 (de)
JP (1) JP5234668B2 (de)
CN (1) CN101563612B (de)
AT (1) ATE414281T1 (de)
AU (1) AU2007280631B2 (de)
CA (1) CA2658904A1 (de)
DE (1) DE602006003651D1 (de)
DK (1) DK1887359T3 (de)
ES (1) ES2317382T3 (de)
HK (1) HK1111218A1 (de)
WO (1) WO2008015013A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG174086A1 (en) 2006-08-30 2011-09-29 Cellzome Ltd Triazole derivatives as kinase inhibitors
SG186040A1 (en) 2007-11-27 2012-12-28 Cellzome Ltd Amino triazoles as pi3k inhibitors
AU2009211845A1 (en) * 2008-02-04 2009-08-13 Cellzome Gmbh Selectivity profiling of PI3K interacting molecules against multiple targets
ATE547707T1 (de) * 2008-05-16 2012-03-15 Cellzome Ag Verfahren zur identifizierung von mit parp wechselwirkenden molekülen und zur aufreinigung von parp-proteinen
WO2010092015A1 (en) 2009-02-10 2010-08-19 Cellzome Limited Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
CA2755061A1 (en) 2009-03-13 2010-09-16 Cellzome Limited Pyrimidine derivatives as mtor inhibitors
ES2423804T3 (es) 2009-04-03 2013-09-24 Cellzome Gmbh Métodos para la identificación de moléculas que interaccionan con cinasas y para la purificación de proteínas de cinasa
US8367830B2 (en) 2009-05-20 2013-02-05 Cellzome Ag Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
US9249129B2 (en) 2010-03-04 2016-02-02 Cellzome Limited Morpholino substituted urea derivatives as mTOR inhibitors
US20140163023A1 (en) 2011-04-04 2014-06-12 Cellzome Limited Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
BR112014006743A8 (pt) 2011-09-21 2018-01-09 Cellzome Ltd composto, uso de um composto, e, método para tratar, controlar, retardar ou impedir uma ou mais condições
US9242993B2 (en) 2011-10-07 2016-01-26 Cellzome Limited Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors
US20160022757A1 (en) * 2013-03-15 2016-01-28 Icahn School Of Medicine At Mount Sinai Therapeutic methods for treating solid tumors and related diagnostic methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952512A (en) * 1984-06-22 1990-08-28 Loskutoff David J Gene encoding an inhibitor of tissue-type and urokinase-type plasminogen activators
US5994082A (en) * 1994-08-26 1999-11-30 Mach; Bernard Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity
CA2239463A1 (en) * 1996-11-01 1998-05-14 Onyx Pharmaceuticals, Inc. Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
PE20030968A1 (es) * 2002-02-28 2004-01-12 Novartis Ag Derivados de 5-feniltiazol como inhibidores de cinasas
KR20060070572A (ko) * 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Ｈｓｐ90-저해제로서의 신규 헤테로시클릭 화합물
SE0402735D0 (sv) * 2004-11-09 2004-11-09 Astrazeneca Ab Novel compounds
WO2006134056A1 (en) 2005-06-14 2006-12-21 Cellzome Ag Process for the identification of novel enzyme interacting compounds
AU2009211845A1 (en) 2008-02-04 2009-08-13 Cellzome Gmbh Selectivity profiling of PI3K interacting molecules against multiple targets

Also Published As

Publication number Publication date
JP5234668B2 (ja) 2013-07-10
DK1887359T3 (da) 2009-03-02
WO2008015013A1 (en) 2008-02-07
DE602006003651D1 (de) 2008-12-24
US8153389B2 (en) 2012-04-10
HK1111218A1 (en) 2008-08-01
CA2658904A1 (en) 2008-02-07
CN101563612A (zh) 2009-10-21
AU2007280631A1 (en) 2008-02-07
CN101563612B (zh) 2013-05-29
JP2010500870A (ja) 2010-01-14
ES2317382T3 (es) 2009-04-16
EP1887359B1 (de) 2008-11-12
EP1887359A1 (de) 2008-02-13
AU2007280631B2 (en) 2013-02-21
US20100055711A1 (en) 2010-03-04

Similar Documents

Publication Publication Date Title
ATE414281T1 (de) Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k
ATE417274T1 (de) Verfahren zur identifizierung von mit zap-70 wechselwirkenden molekülen und zur zap-70- reinigung
ATE452208T1 (de) Verfahren zum nachweis einer zielsubstanz unter verwendung einer nukleinsäuresonde
WO2006124644A3 (en) Protein and antibody profiling using small molecule microarrays
WO2012012345A3 (en) Method for automated determination of an optimally parameterized scatterometry model
WO2004091523A3 (en) Method for identifying ligands specific for structural isoforms of proteins
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
NZ609824A (en) Immunochromatography devices, methods and kits
BRPI0512378A (pt) método para clarificação de amostra de célula em escala industrial
WO2006031644A3 (en) Immobilized probes and methods of detecting conformationally altered prion proteins
Coninx et al. Hippocampal and cortical tissue-specific epigenetic clocks indicate an increased epigenetic age in a mouse model for Alzheimer’s disease
CA2735129A1 (en) Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
WO2010056681A3 (en) Thyroid analyte detection and measurement
EP1816476A4 (de) Testverfahren für nukleinsäurebindendes protein auf biochipbasis
WO2006110748A3 (en) Response gene to complement 32 (rgc-32) in disease
GB0618496D0 (en) Blood typing
ATE343789T1 (de) Biomolekulares kinetik-messverfahren mit hilfe von einem durchfluss-mikroarray
EP2507619A4 (de) Verfahren und system zur bindungsverhaltensanalyse
DE69924128D1 (de) Verfahren zur erkennung von verbindungen,die die wechselwirkung von rna und rna-bindungsproteinen beinflussen
WO2006008633A3 (en) Receptor protein tyrosine phosphatase gamma (ptprg) as marker for dendritic cells cells
ATE440968T1 (de) Verfahren zur diagnostizierung von aspirinunverträglichkeit
DE60034880D1 (de) Ceramidasegen
SE0301058D0 (sv) Method and kit for cell analyte assay
WO2006051303A8 (en) Assay for measuring an enzyme’s capability to modify supercoil topology of nucleic acids and modulators

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1887359

Country of ref document: EP